|
T-cells (CD3)% of total T cells
|
113
|
79.91 (6.78)
|
77.67 (8.18)
|
61-85
|
0.001
|
In normal range but significantly decreased after treatment
|
|
Helper T-cell (Th cell/CD4) % of total T cells
|
114
|
48.84 (9.03)
|
45.44 (10.65)
|
28-58
|
<0.001
|
In normal range but significantly decreased after treatment
|
|
Ts cell (CD8)% of total T cells
|
114
|
25.38 (7.18)
|
26.89 (8.10)
|
19-48
|
0.005
|
In normal range but significantly increased after treatment
|
|
CD4/CD8
|
114
|
0.30 (0.20)
|
0.24 (0.23)
|
-0.05-0.30
|
<0.001
|
In normal range but significantly decreased after treatment
|
|
IgG (g/L)
|
114
|
0.96 (0.12)
|
0.91 (0.14)
|
0.86-1.23
|
<0.001
|
In normal range but significantly decreased after treatment
|
|
IgA (g/L)
|
114
|
2.15 (0.79)
|
2.01 (0.72)
|
0.68-3.83
|
<0.001
|
In normal range but significantly decreased after treatment
|
|
IgM (g/L)
|
114
|
1.13 (0.62)
|
1.32 (0.72)
|
0.63-2.77
|
<0.001
|
In normal range but significantly increased after treatment
|
|
Complement C3 (g/L)
|
114
|
1.19 (0.23)
|
1.21 (0.25)
|
0.85-1.93
|
0.103
|
In normal range but no significant changes after treatment
|
|
Complement C4 (g/L)
|
114
|
-0.62 (0.17)
|
-0.63 (-0.16)
|
-0.92 - -0.44
|
0.283
|
In normal range but no significant changes after treatment
|
